Nucleosides And Darunavir/Dolutegravir In Africa

NCT03988452 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

465

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DRUG: Darunavir
DRUG: Ritonavir
DRUG: Dolutegravir
DRUG: Zidovudine
DRUG: Tenofovir
DRUG: Lamivudine

Sponsor

Makerere University

Collaborators

[object Object]